Form 4 filed by MURPHY ANDREW J
MURPHY ANDREW J filed this Form 4 on REGN (REGENERON PHARMACEUTICALS, INC.) with 19 transaction rows and 1 holding row, accepted by EDGAR 2026-11-18 21:07:19 UTC.
- Accession
- 0001796226-26-000006
- Filer
- CIK 1796226
- Filed
- 2026-11-18
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: REGN · REGENERON PHARMACEUTICALS, INC. (CIK 872589)
- MURPHY ANDREW J officer (Co-Chief Scientific Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-16 | M exercised | +17,000 | $381.92 | 63,779 | D |
| Common Stock | 2026-11-16 | F withheld for tax | -11,989 | $960.02 | 51,790 | D |
| Common Stock | 2026-11-17 | S sold | -93 | $949.69 | 51,697 | D |
| Common Stock | 2026-11-17 | S sold | -74 | $950.61 | 51,623 | D |
| Common Stock | 2026-11-17 | S sold | -298 | $951.75 | 51,325 | D |
| Common Stock | 2026-11-17 | S sold | -220 | $952.75 | 51,105 | D |
| Common Stock | 2026-11-17 | S sold | -671 | $953.69 | 50,434 | D |
| Common Stock | 2026-11-17 | S sold | -313 | $954.45 | 50,121 | D |
| Common Stock | 2026-11-17 | S sold | -313 | $955.48 | 49,808 | D |
| Common Stock | 2026-11-17 | S sold | -346 | $956.7 | 49,462 | D |
| Common Stock | 2026-11-17 | S sold | -202 | $957.53 | 49,260 | D |
| Common Stock | 2026-11-17 | S sold | -244 | $958.27 | 49,016 | D |
| Common Stock | 2026-11-17 | S sold | -506 | $959.45 | 48,510 | D |
| Common Stock | 2026-11-17 | S sold | -257 | $960.65 | 48,253 | D |
| Common Stock | 2026-11-17 | S sold | -584 | $961.45 | 47,669 | D |
| Common Stock | 2026-11-17 | S sold | -295 | $962.7 | 47,374 | D |
| Common Stock | 2026-11-17 | S sold | -255 | $963.6 | 47,119 | D |
| Common Stock | 2026-11-17 | S sold | -340 | $964.36 | 46,779 | D |
| Common Stock holding | 4,414 | I By 401(k) Plan | ||||
| Non-Qualified Stock Option (right to buy) derivative | 2026-11-16 | M exercised | -17,000 | $0 | 0 | D |